Titus Podcast! Cancer Therapy Game Changer + eGenesis Raises $191M for Xenotransplants

Hi ,

Can you believe that there are only 194 days until SynBioBeta 2025? Yeah, we can' t believe it either. Well, we're working hard to bring you the best conference yet. So make sure you stay up to date with all the latest event news and industry advancements right here. And remember, it's never too early to get your 2025 conference tickets!

Join Leaders Like Jodi Barrientos at SynBioBeta 2025

Jodi Barrientos, CEO of Ribbon Biolabs, describes the SynBioBeta stage as a critical platform for leaders to share significant advances with peers who understand their impact. Be part of the ultimate gathering for those leading the synthetic biology revolution.

New SynBioBeta 2025 Speakers Announced!

Check Out Our Latest Sponsors and Exhibitors for SynBioBeta 2025!

Bioeconomy Lessons with Titus. A lot is happening in the bioeconomy, from AI to scale-up innovation to new government policies. For this episode, host Fiona Mischel sat down with renowned bioeconomy leader Alexander Titus to help sort out the hype from reality and see opportunities where most might see pitfalls. Take a listen

The One Mutation That Could Change Cancer Therapy Forever

A single mutation in the HER2 protein is being targeted with unprecedented precision, offering a new, less toxic approach to cancer therapy.

eGenesis Raises $191M to Lead the Future of Cross-Species Kidney Transplants

The future of organ transplants takes a leap forward as the company secures $191M to advance its kidney transplant programs.

Cracking the Code of Kokumi: The Key to Full-Bodied Cheese Flavor

Mold cultures might be the secret to speeding up flavor development in aged cheeses, thanks to new insights from food scientists.

US EPA Approves Expanded Biosurfactant Production List for Locus FS

With EPA certification, Locus FS solidifies its leadership in the biomanufacturing space, offering eco-friendly alternatives to traditional chemical ingredients.